Skip to main content

Table 1 Demographics of focus group discussion and in-depth interview participants (N = 28)

From: Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers

  HIV-positive individuals on ART HIV-negative individuals on PrEP (n = 4) Providers (n = 8)
Viral load < 200 copies/mL (n = 10)* Viral load ≥ 200 copies/mL (n = 6)**
Gender
 Male 6 5 4 4
 Female 3 1 0 4
 Transgender female 1 0 0 0
Age, median (range) 57 (39–65) 48 (32–57) 35 (31–55) 49 (38–65)
Race
 American Indian/Alaskan Native 2 0 0 0
 Asian 1 0 0 3
 Black/African American 4 3 0 0
 Native Hawaiian/Pacific Islander 0 1 0 0
 White 3 2 3 5
 Other 0 0 1 0
Latino/Hispanic/Chicano 0 0 2 0
Highest Level of Education
 Some secondary education/high school (9–12 years) 2 0 0 0
 High school graduate or GED 3 5 1 0
 College or associates degree 4 1 2 0
 Advanced degree 0 0 1 8
Years on HIV medications
  < 1 year 0 1 1 –
 1–5 years 1 1 3 –
  > 5–10 years 2 0 0 –
 > 10 years 7 4 0 –
Years providing care for ART/PrEP
 < 5 years – – – 1
 5–20 years – – – 3
 > 20 years – – – 4
  1. GED general education diploma, ART antiretroviral therapy, PrEP pre-exposure prophylaxis
  2. *Data missing for one participant for highest level of education
  3. **Data missing for one participant for all characteristics
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us

\